Rockefeller Capital Management
SUPN icon

Rockefeller Capital Management’s Supernus Pharmaceuticals SUPN Stock Holding History

Rockefeller Capital Management’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$70.7K Sell
1,520
-424
-22% -$20.4K ﹤0.01% 3177
2026
Q1 		$100K Buy
1,944
+1,098
+130% +$55.9K ﹤0.01% 2871
2025
Q4 		$42K Buy
846
+660
+355% +$32.1K ﹤0.01% 3150
2025
Q3 		$8.89K Buy
+186
New +$7.49K ﹤0.01% 3695
2023
Q1 		– Sell
-18
Closed – – 3667
2022
Q4 		$0 Hold
18
– – ﹤0.01% 4196
2022
Q3 		$0 Sell
18
-124
-87% -$4.04K ﹤0.01% 4352
2022
Q2 		$4K Buy
142
+59
+71% +$1.69K ﹤0.01% 3574
2022
Q1 		$2K Sell
83
-248
-75% -$7.6K ﹤0.01% 3640
2021
Q4 		$9K Buy
+331
New +$10K ﹤0.01% 3038
2020
Q4 		– Sell
-315
Closed -$6K – 3001
2020
Q3 		$6K Buy
315
+64
+25% +$1.45K ﹤0.01% 2179
2020
Q2 		$6K Sell
251
-202
-45% -$4.46K ﹤0.01% 2060
2020
Q1 		$8K Buy
453
+323
+248% +$6.79K ﹤0.01% 1827
2019
Q4 		$3K Sell
130
-1,163
-90% -$28.2K ﹤0.01% 1880
2019
Q3 		$36K Sell
1,293
-30
-2% -$889 ﹤0.01% 1070
2019
Q2 		$44K Buy
1,323
+241
+22% +$8.26K ﹤0.01% 837
2019
Q1 		$38K Buy
1,082
+757
+233% +$28.2K ﹤0.01% 999
2018
Q4 		$11K Hold
325
– – ﹤0.01% 689
2018
Q3 		$16K Hold
325
– – ﹤0.01% 533
2018
Q2 		$19K Buy
+325
New +$16.8K ﹤0.01% 536

Other funds holding SUPN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

Rockefeller Capital Management's SUPN Position: Q2 2026 in Review

Rockefeller Capital Management reduced its Supernus Pharmaceuticals (SUPN) stake by 22% in Q2 2026, selling an estimated $20.4K and leaving 1,520 shares worth $70.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3177.

Rockefeller Capital Management first reported a position in SUPN in Q2 2018 and has held it in 19 quarters since. The position peaked at $100K in Q1 2026. 332 funds tracked by Wall St. Rank hold SUPN as of Q2 2026.

  • Rockefeller Capital Management held 1,520 shares of Supernus Pharmaceuticals worth $70.7K as of Q2 2026.
  • Rockefeller Capital Management sold 424 Supernus Pharmaceuticals shares in Q2 2026, an estimated $20.4K.
  • Supernus Pharmaceuticals made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #3177 holding.
  • Rockefeller Capital Management first reported a position in Supernus Pharmaceuticals in Q2 2018 and has held it in 19 quarters since.
  • Rockefeller Capital Management's Supernus Pharmaceuticals position peaked at $100K in Q1 2026.
  • 332 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.